Eko Foundation Analysis Software with Transformers (EFAST) vs Mindbowser AI Cardiovascular Risk Prediction

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Eko Foundation Analysis Software with Transformers (EFAST)
by Eko Health
VS
Mindbowser AI Cardiovascular Risk Prediction
by Mindbowser

AI Verdict

EFAST by Eko Health provides real-time AI-powered detection of existing cardiac conditions like structural murmurs and atrial fibrillation during auscultation, integrating with their digital stethoscopes. Mindbowser's AI Cardiovascular Risk Prediction, conversely, focuses on predicting future cardiovascular risks and offering clinical decision support through deep EHR integration. While both tools aim to enhance cardiac care, EFAST serves as a diagnostic aid for immediate findings, whereas Mindbowser provides predictive analytics for long-term risk management.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if your primary need is real-time, AI-powered cardiac screening at the point of care during routine physical examinations. This tool is ideal for clinicians seeking immediate insights into structural murmurs and atrial fibrillation, directly integrating with digital stethoscopes for enhanced auscultation and rapid decision-making.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose Mindbowser AI Cardiovascular Risk Prediction if…

Choose Mindbowser AI Cardiovascular Risk Prediction if your organization requires a comprehensive, system-wide solution for assessing and managing cardiovascular risk across a patient population. This tool is best suited for providers and hospitals looking to integrate AI-driven risk stratification with existing EHR systems to enhance clinical decision support and data analytics for population health initiatives.

View Mindbowser AI Cardiovascular Risk Prediction →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) Mindbowser AI Cardiovascular Risk Prediction
Pricing Subscription-based, contact for details Contact for pricing
Deployment Unknown Cloud-based
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST offers a highly integrated and real-time user experience, providing AI analysis directly during auscultation with enhanced audio and waveform visualization. This seamless integration with Eko digital stethoscopes suggests a more direct and intuitive workflow for clinicians at the point of care.

Clinical Value

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST provides specific, FDA-cleared diagnostic capabilities for structural murmurs (93% sensitivity, 91% specificity) and AFib (95% sensitivity, 94% specificity), offering real-time, actionable insights for immediate clinical decisions. Mindbowser's tool focuses on risk prediction, which is valuable but distinct from direct diagnostic aid.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A offers more transparency by stating it is subscription-based, includes an Eko+ membership, and provides a daily cost equivalent for its stethoscope technology, along with a free trial. Tool B only states 'contact for pricing,' making a direct value comparison difficult.

Enterprise Readiness

Mindbowser AI Cardiovascular Risk Prediction

Both tools are HIPAA compliant and cloud-based with EMR/EHR integration. However, Tool B explicitly mentions SOC 2 compliance and specific EHR integrations with Epic, Cerner, Athenahealth, and support for HL7 & FHIR interoperability, indicating a broader and more detailed approach to enterprise integration.

Innovation

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A demonstrates a more innovative application by integrating advanced AI directly into the traditional auscultation process with real-time diagnostic feedback for specific cardiac conditions. This enhances a fundamental clinical examination with immediate, high-accuracy AI insights.

Support & Docs

Eko Foundation Analysis Software with Transformers (EFAST)

Eko Health provides a comprehensive Help Center with readily available user manuals, quick start guides, and detailed articles specific to the EFAST algorithm, indicating robust documentation and support resources. Specific documentation and support details for Mindbowser's tool are less explicitly detailed in the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) Mindbowser AI Cardiovascular Risk Prediction
Name Eko Foundation Analysis Software with Transformers (EFAST) Mindbowser AI Cardiovascular Risk Prediction
Company Eko Health Mindbowser
Description EFAST by Eko Health is an advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. Mindbowser's AI Cardiovascular Risk Prediction tool is part of their comprehensive suite of healthcare AI solutions, designed for providers and hospitals to assess cardiovascular risks. It emphasizes compliance with HIPAA and SOC 2 and integrates with leading EHR systems.
Key Features AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation; Enhanced audio with noise cancellation and amplification; Waveform visualization and guided exams; Seamless integration with Eko digital stethoscopes (e.g., CORE 500); Cloud-based recording and secure storage of exams; EMR integration for streamlined documentation AI Cardiovascular Risk Prediction; AI-powered automation; HIPAA and SOC 2 compliance; EHR integration (Epic, Cerner, Athenahealth, FHIR); Clinical Decision Support System; Data & Analytics; HL7 & FHIR interoperability; Secure, compliant healthcare data access

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and Mindbowser AI Cardiovascular Risk Prediction.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EFAST by Eko Health is an FDA-cleared AI model designed to provide real-time assistance during routine exams by identifying structural murmurs associated with heart disease and detecting atrial fibrillation. Mindbowser's AI Cardiovascular Risk Prediction tool, on the other hand, focuses on assessing overall cardiovascular risks for patients and providing clinical decision support, likely leveraging existing patient data from EHRs.
Yes, EFAST is an FDA-cleared AI model specifically for detecting structural heart murmurs and atrial fibrillation. Mindbowser's AI Cardiovascular Risk Prediction tool emphasizes compliance with HIPAA and SOC 2, but the provided information does not explicitly state FDA clearance for its risk prediction capabilities.
EFAST offers EMR integration for streamlined documentation and seamlessly integrates with Eko digital stethoscopes. Mindbowser's tool emphasizes broad EHR integration with leading systems like Epic, Cerner, and Athenahealth, and supports HL7 & FHIR interoperability for secure data exchange.
EFAST provides specific performance metrics for its AI, including 93% sensitivity and 91% specificity for structural murmur detection, and 95% sensitivity and 94% specificity for AFib detection. Mindbowser's description highlights AI Cardiovascular Risk Prediction but does not provide specific sensitivity or specificity metrics for its risk prediction.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Eko Foundation Analysis Software with Transformers (EFAST) or Mindbowser AI Cardiovascular Risk Prediction

Backers

Who funded each tool's parent company.

Eko Foundation Analysis Software with Transformers (EFAST)

AI Tool Finder
AI-powered search. Results may not be comprehensive.